Abstract:Background Endogenously produced hydrogen sulfide (H 2 S) may have multiple functions in brain. An increasing number of studies have demonstrated its anti-inflammatory effects. In the present study, we investigated the effect of sodium hydrosulfide (NaHS, a H 2 S donor) on cognitive impairment and neuroinflammatory changes induced by injections of Amyloid-β 1-40 (Aβ 1-40 ), and explored possible mechanisms of action. Methods We injected Aβ 1-40 into the hippocampus of rats to mimic rat model of Alzheimer’s disease (AD). Morris water maze was used to detect the cognitive function. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay was performed to detect neuronal apoptosis. Immunohistochemistry analyzed the response of glia. The expression of interleukin (IL)-1β and tumor necrosis factor (TNF)-α was measured by enzyme-linked immunosorbent assay (ELISA) and quantitative real-time polymerase chain reaction (qRT-PCR). The expression of Aβ 1-40 , phospho-p38 mitogen-activated protein kinase (MAPK), phospho-p65 Nuclear factor (NF)-κB, and phospho-c-Jun N-terminal Kinase (JNK) was analyzed by western blot. Results We demonstrated that pretreatment with NaHS ameliorated learning and memory deficits in an Aβ 1-40 rat model of AD. NaHS treatment suppressed Aβ 1-40 -induced apoptosis in the CA1 subfield of the hippocampus. Moreover, the over-expression in IL-1β and TNF-α as well as the extensive astrogliosis and microgliosis in the hippocampus induced by Aβ 1-40 were significantly reduced following administration of NaHS. Concomitantly, treatment with NaHS alleviated the levels of p38 MAPK and p65 NF-κB phosphorylation but not JNK phosphorylation that occurred in the Aβ 1-40 -injected hippocampus. Conclusions These results indicate that NaHS could significantly ameliorate Aβ 1-40 -induced spatial learning and memory impairment, apoptosis, and neuroinflammation at least in part via the inhibition of p38 MAPK and p65 NF-κB activity, suggesting that administration of NaHS could provide a therapeutic approach for AD.

RETRACTED: S14G-Humanin Ameliorates Aβ25-35-induced Behavioral Deficits by Reducing Neuroinflammatory Responses and Apoptosis in Mice

S14G-Humanin Improves Cognitive Deficits and Reduces Amyloid Pathology in the Middle-Aged APPswe/PS1dE9 Mice

Protective Effect of S14G-humanin Against Beta-Amyloid Induced LTP Inhibition in Mouse Hippocampal Slices.

Retracted: S14G‐humanin Inhibits Aβ1–42 Fibril Formation, Disaggregates Preformed Fibrils, and Protects Against Aβ‐induced Cytotoxicity in Vitro

Effect of humanin and [Gly14]-humanin on expression of hippocampal glial fibrillary acidic protein in mice with Alzheimer disease

S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.

Protective effects of [Gly14]-Humanin on β-amyloid-induced PC12 cell death by preventing mitochondrial dysfunction

A New Chiral Pyrrolyl Alpha-Nitronyl Nitroxide Radical Attenuates Beta-Amyloid Deposition And Rescues Memory Deficits In A Mouse Model Of Alzheimer Disease

Hydrogen Sulfide Attenuates Spatial Memory Impairment and Hippocampal Neuroinflammation in Beta-Amyloid Rat Model of Alzheimer’s Disease

A New Chiral Pyrrolyl α-Nitronyl Nitroxide Radical Attenuates β-Amyloid Deposition and Rescues Memory Deficits in a Mouse Model of Alzheimer Disease

Protective Effect of Recombinant Human Somatotropin on Amyloid Beta-Peptide Induced Learning and Memory Deficits in Mice.

[Gly14]-Humanin Reduces Histopathology and Improves Functional Outcome after Traumatic Brain Injury in Mice.

[Gly14]-Humanin Offers Neuroprotection Through Glycogen Synthase Kinase-3Β Inhibition in a Mouse Model of Intracerebral Hemorrhage

Neuroprotective, Anti-Amyloidogenic and Neurotrophic Effects of Apigenin in an Alzheimer’s Disease Mouse Model

Protective Effects of 1-Methylnicotinamide on Aβ 1–42 -Induced Cognitive Deficits, Neuroinflammation and Apoptosis in Mice

Retraction Notice to “S14g-Humanin Ameliorates Aβ 25-35-induced Behavioral Deficits by Reducing Neuroinflammatory Responses and Apoptosis in Mice” [neuropeptides 42/5-6 (2008) 557–567]

Diammonium Glycyrrhizinate Attenuates Aβ1–42‐Induced Neuroinflammation and Regulates MAPK and NF‐κB Pathways in Vitro and in Vivo

Humanin peptides block calcium influx of rat hippocampal neurons by altering fibrogenesis of Aβ1–40

Ginsenoside Rg1 alleviates learning and memory impairments and Aβ disposition through inhibiting NLRP1 inflammasome and autophagy dysfunction in APP/PS1 mice

Intranasal Administration of TAT-haFGF14–154 Attenuates Disease Progression in a Mouse Model of Alzheimer’s Disease

Humanin Analogue, HNG, Inhibits Platelet Activation and Thrombus Formation by Stabilizing Platelet Microtubules